New
Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
364970 ETF · Mirae Asset TIGER BIO TOP10 ETF
The 364970 Exchange Traded Fund (ETF) is provided by Mirae Asset Global Investments. It is built to track an index: KRX Bio TOP 10 Index. The 364970 ETF provides physical exposure, so by buying it you actually own parts of all the 11 underlying holdings. This share class generates a stream of income by distributing dividends.
Last update 3/13/2026, 12:00 AM UTC
LIVE
CLOSED
This fund is part ofAPAC Blended Cap1M perf.-5.35%
Last price
â‚©8,300
1M perf.
-7.71%
1M flows
-€14M
AuM
€170M
E/R
0.42%
Rating
Not rated
ESG Consensus®
364970
â‚©8,300
Performance & flows
Segment for quartile rank
December 11, 2025 → March 11, 2026
Create a free account to view the flows graph
364970
â‚©8,416.18
-3.75%
APAC Blended Cap
+9.55%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -7.71%  | -3.75% | +7.31% | +49.65%  | -14.54% | -11.01% | -6.27% | -6.27% | |
| Flows |
Key fund info
Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) ·
Main characteristics
ISIN
KR7364970004
AuM
€170M
E/R
0.42%
Replication rating
Not rated
ESG Consensus®
More details
NAV
3/11/2026
â‚©8,416.18
1D NAV change
-2.02%
Dividend policy
Replication method
Direct (Physical)
Replication model
Optimized sampling
No. of holdings
11
Inception date
10/7/2020
Jurisdiction
South Korea
Distribution
South Korea
Legal structure
Open-end Fund
Base currency
KRW
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Investment strategy
Mirae Asset TIGER BIO TOP10 ETF is an exhcange-traded fund extablished in South Korea. The fund aims to provide return that closely replicates the performance of the KRX Bio TOP 10 Index.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSimilar ETFs in your region
227540
1M perf.
-9.81%
E/R
0.4%
Advertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -3.75% | +7.31% | +49.65% | -14.54% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
Republic of Korea
98.82%
Unavailable
1.18%
Sectors
Health Care
81.57%
Consumer Discretionary
4.60%
Unavailable
13.83%
Diversification
Total weight of top 11 holdings out of 11
Top 11 holdings
Data as of January 31, 2026
CELLTRION
ALTEOGEN INC
SAMSUNG BIOLOGICS CO LTD
KR70126Z0002
PEPTRON
YUHAN
Create a free account to view top holdings
HLB
LEGOCHEM BIOSCIENCES
SK BIOPHARMACEUTICALS CO LTD
PHARMARESEARCH CO LTD
HUGEL
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
No
SDG
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
Mirae Asset Global Investments
Mirae Asset Global Investments ID Card
Number of funds
100
Total AuM
€28.92B
Expense ratio range
0.05% - 1%
Average expense ratio
0.3878%
Top 5 funds by Mirae Asset Global Investments
| AuM | ||
|---|---|---|
133690 | Mirae Asset TIGER NASDAQ 100 ETF | €4.65B |
396500 | Mirae Asset TIGER Fn Semiconductor TOP10 ETF | €4.58B |
102110 | Mirae Asset TIGER 200 ETF | €4.29B |
381170 | Mirae Asset TIGER US Tech TOP10 INDXX ETF | €2.23B |
292150 | MIRAE ASSET TIGER TOP 10 ETF | €1.35B |
Frequently asked questions about 364970
What does Mirae Asset TIGER BIO TOP10 ETF, 364970, invest in?
364970 is a Passive ETF. This ETF provides exposure to South Korean Equities.
Which benchmark or index does 364970 replicate?
364970 tracks the KRX Bio TOP 10 Index - KRW, through a optimized sampling replication method.
What is the Total Expense ratio (TER) of 364970?
364970 carries a total expense ratio (TER) of 0.42%, indicating the annual cost for holding the fund.
When was 364970 launched?
364970 was introduced to the market on October 7, 2020. It trades on South Korea
Who is the ETF issuer of 364970?
Mirae Asset TIGER BIO TOP10 ETF, 364970, is provided by Mirae Asset Global Investments. Learn more about Mirae Asset Global Investments here.
What is the current assets under management (AUM) of 364970?
364970 oversees €170M in assets as of March 11, 2026.
How has 364970 performed lately?
Based on data from March 11, 2026, 364970 returned -7.71% over the past month, -3.75% over the last three months and -6.27% year-to-date.
What are the latest inflows or outflows for 364970?
As of March 11, 2026, 364970 recorded net flows of -€14M over the last month and +€10M year-to-date.
Does 364970 distribute dividends?
364970 follows a distributing dividend policy, meaning it pays out income to investors. As of March 11, 2026, its 12-month trailing yield was 0.12%.
What are the main country or region exposures of 364970?
As of January 31, 2026, 364970 has significant geographic allocations in Republic of Korea.
In which sector or theme does 364970 invest in?
As of January 31, 2026, 364970 focuses largely on Health Care and Consumer Discretionary.
How many securities does 364970 hold and how diversified is it?
As of January 31, 2026, 364970 holds 11 positions in its portfolio, with 98.82% of assets concentrated in its top 15 holdings.
What are the main positions in 364970?
As of January 31, 2026, 364970 top three holdings include CELLTRION, ALTEOGEN INC and SAMSUNG BIOLOGICS CO LTD.
What is the base currency of 364970?
The base currency of 364970 is KRW.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
